Leverage our Ready-to-Use Clinical Study Platform with integrated EDC, Medical Coding, CTMS and Drug Safety Applications
‘AccelStudy’ is a full-managed, cloud-based integrated solutions platform designed for biopharmaceutical and medical device companies to perform clinical data management, trial management, and manage drug safety functions in a single place. Clients can realize significant benefits almost immediately with a ready-to-use, validated and industry recognized application suite. Our flexible pricing model can lower the total cost of ownership.
What is Offered with AccelStudy
The ‘AccelStudy’ platform has a robust EDC, CTMS and a Drug Safety System which allows clients to centrally manage the entire lifecycle of a clinical study. It also includes the study design support services from Techsol for setting up sites, investigators, study visits and the associated case report forms.
Solution Subscription Model
> Clients can subscribe for one study or for multiple studies in a program by selecting only the required modules for their business need
> The technical solution is offered with ancillary services such as Study Build, Edit Checks Programming, Setting up Data Extraction schedules, and developing custom reports
> Additional System integrations with eCOA, IVRS/IWRS, etc. can be optionally selected as part of the subscription
‘AccelStudy’ is delivered on a GxP compliant fully-managed cloud platform hosted on Amazon Web Services (AWS) which has security and quality certifications such as ISO 9001, ISO 27001, ISO 27017 and ISO 27018.
All ongoing systems validation and preventive maintenance of the AccelStudy platform and associated add-on applications will be managed by Techsol throughout the business lifecycle.
- Techsol owns the responsibility for the end-to-end management of all applications
- Burden of validation & compliance management is significantly reduced
- Security option with Single sign-on is available
- Includes all future application version upgrades, dictionary upgrades, and security updates
- Considerably reduces Total Cost of Ownership (TCO)